The Jefferies Global Healthcare Conference kicked off with a bang this week, including a pair of billion-dollar M&A deals, a major bet on U.K. biotech, and a new biopharma crossover fund.
Why it matters: Jefferies is gaining ground on JPMorgan's January conference as a must-attend venue for biotech dealmakers, attendees tell Axios Pro.